WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation
• 3 years agoThe Regeneron cocktail of synthetic antibodies - casirivimab and imdevimab - has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid.
Dr Reddy's DRDO-produced drug 2DG launches commercially: Cost, production, efficacy
Tech2 News Staff • 4 years agoThe drug comes in powder form in a sachet of 2.34 g and the MRP has been fixed at Rs 990.
New software enables early identification of COVID-19 patients who may need ventilator support
• 4 years agoThe algorithm was developed by the Foundation for Innovations in Health, Kolkata and SEED division of the Department of Science and Technology.
Separate wards, medical teams in Maharashtra hospitals to treat Mucormycosis, says Rajesh Tope
• 4 years agoThe state government has decided to set up separate wards as treatment for Mucormycosis, also known as black fungus infection, needed ophthalmologists, ENT specialists, neuro and plastic surgeons, etc, under the same roof
No GST on black fungus medicines, 5% tax on vaccines to stay: Complete list of tax cuts on COVID essentials
Fp Staff • 4 years agoThe Council stated that tax cuts will remain in effect till 30 September, and can be extended further upon nearing the deadline
COVID-19 impact: Odisha techie airlifted to Chennai for treatment after kin raise Rs 70 lakh via crowdfunding
Trendingdesk • 4 years agoThe 24-year-old techie had contracted COVID-19 while taking care of his corona-positive parents. He later developed pneumonia and septicaemia in the lungs and requires a lung transplant to stay alive
Unseen Warriors of COVID: In UP's Bijnor, paramedics and local doctors help villagers wary of hospitals
Aasmohammad Kaif • 4 years agoFrom checking up on patients showing symptoms of COVID-19, to providing them with medicines at low cost, physicians and paramedic staff provided the much-needed care as Bijnor battled the second wave
Will COVID-19 third wave hit children hard? Health ministry issues guidelines; all you need to know
Tech2 News Staff • 4 years agoThese guidelines are categorised on the basis of severity of the infection: mild and asymptomatic, moderate and severe.
Roche launches COVID-19 'Antibody Cocktail' in India at Rs 59,750 per dose; Cipla to market drug in country
• 4 years agoIn a joint statement, the pharma giants said that the second batch of the Antibody Cocktail (Casirivimab and Imdevimab) will be available by mid-June
No evidence of Remdesivir's effectiveness, might be dropped as COVID-19 treatment: Dr DS Rana
• 4 years agoGanga Ram hospital Chairperson Dr DS Rana said, "Medicines that do not have any activity to work, will have to be discontinued."